Hormone replacement therapy (HRT, primarily estrogen) and selective estrogen receptor modulators (SERMs) improve metabolic disorders, including obesity, type 2 diabetes, dyslipidemia, and osteoarthritis, by activating estrogen receptor-related pathways [9, 10]. Here, ESR1 is linked to Obesity.